Advanced search×

[Principles of the management of adult inguinal hernia--recommendations by the European Hernia Society].

György G Wéber and

Magy Seb 63(5):287-96 (2010) PMID 20965861

The European Hernia Society (EHS) presented the EHS Guidelines for the Treatment of Inguinal Hernia in Adult Patients. The Guidelines contain recommendations for the management of inguinal hernia from diagnosis to aftercare. These have been developed by a Working Group consisting of expert surgeons with representatives of 14 member countries of the EHS. The Guidelines are evidence-based and, when necessary, a consensus of all members was reached. The Guidelines have been reviewed by a Steering Committee as well. Before finalisation, feedback from the relevant national hernia societies was obtained. The Guidelines can be used to adjust local protocols, training purposes as well as quality control. In order to keep them updated the next revision will be published in 2012. A short update of new high-level evidence will be provided by the Working Group during the EHS annual congress until the next revision.

References 2 articles

DOI: 10.1556/MaSeb.63.2010.5.1
Version: za2963e q8za1 q8zb8 q8zc9 q8zd2 q8zec q8zf2 q8zgf
Buy PDF

Similar articles you may find interesting…

  1. Improving tension decrease in components separation technique.
    M V J Barbosa, N A M Ayaviri, and L M Ferreira

    Hernia (2013) PMID 23649404

    There was a progressive and significant decrease in tension along the stages (Friedman's analysis of variance, p < 0.001). Traction indexes were higher in the initial stage and became gradually lower along the other stages. CONCLUSION: The undermining of the anterior rectus sheaths helps to decrea...
    Buy PDF
  2. Human simulated studies of Aztreonam and Aztreonam-Avibactam to evaluate activity against Challenging Gram-negative Organisms, including Met...
    Jared L Crandon and David P Nicolau

    Antimicrob Agents Chemother (2013) PMID 23650162

    We evaluated the efficacy of human simulated doses of aztreonam-avibactam and aztreonam against 14 Enterobacteriaceae and 13 Pseudomonas aeruginosa, of which 25 produced metallo-beta-lactamases. Additionally, 6 P. aeruginosa isolates were also evaluated in immunocompetent animals. A humanized aztreo...
    Buy PDF
  3. Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy (3C) Study: background, rationale, and study protocol.
    Richard Haynes, Colin Baigent, and Peter Friend

    Transplantation Research 2(1):7 (2013) PMID 23641902

    BACKGROUND: Kidney transplantation is the best treatment for patients with end-stage renal failure, but uncertainty remains about the best immunosuppression strategy. Long-term graft survival has not improved substantially, and one possible explanation is calcineurin inhibitor (CNI)...
    Buy PDF